Ana LLEO

Professor of Internal Medicine

Humanitas University

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Ana LLEO is a faculty member in the Department of Internal Medicine at Humanitas University, Italy. Her research focuses on autoimmune liver diseases, cancer risk associated with obesity, and the application of deep learning in medical diagnostics. Recent publications include investigations into the incidence of complications following liver biopsy and the role of PD-1 in hepatotoxicity. She is actively engaged in exploring innovative treatment approaches for biliary tract cancer and other liver conditions.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (15)

GUIDO TORZILLI

Full Professor of Surgery

Humanitas University

ITALY

Ana LLEO

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Burden of cancer attributable to high body mass index: A systematic analysis of the Global Burden of Disease Study 2021

Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre Study

Is ChatGPT-4 a Reliable Tool in Autoimmune Hepatitis?

Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Increased PD-1 expression in livers associated with PD-1-antibody-induced hepatotoxicity

Mapping the landscape of biliary tract cancer in Europe: challenges and controversies

Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of Cholestasis

Real-world experience with odevixibat in children with progressive familial intrahepatic cholestasis

The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel Immunotherapies

Deep Learning helps discriminating Autoimmune Hepatitis and Primary Biliary Cholangitis

Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence

Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients

Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases

Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases

Versatile Mass Spectrometry-Based Intraoperative Diagnosis of Liver Tumor in a Multiethnic Cohort

Versatile Mass Spectrometry-Based Intraoperative Diagnosis of Liver Tumor in a Multiethnic Cohort

Collaborators (15)

GUIDO TORZILLI

Alessio Aghemo

ciro franzese

Marta Calatroni

Carlo Selmi

Antonio Voza

Alessandro Armuzzi

Giacomo Maria Guidelli

Matteo Luca Vecellio

luca di tommaso

Nicola Pugliese

Nicasio MANCINI

Alessandro Repici

Maria De Santis

Damiano Verda

Make your next move.